← FDA Drug Approvals (Drugs@FDA)

OLUX E

NDA · New Drug Application · Sponsor: PHARMOBEDIENT · Approved 2007-01-12

Drug application

FDA Application #

NDA022013

Application type

New Drug Application

Brand name

OLUX E

Generic name

Clobetasol Propionate

Active ingredients

CLOBETASOL PROPIONATE

Dosage form

AEROSOL, FOAM

Route

TOPICAL

Marketing status

Discontinued

Sponsor

PHARMOBEDIENT

First approval

2007-01-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown